COMMUNIQUÉS West-GlobeNewswire

Cannara Biotech réalise des revenus et une rentabilité records pour l’exercice 2025 et affiche pour la première fois un solde positif de bénéfices non répartis
24/11/2025
R ésultats financiers records pour l'exercice 2025 : total des produits, déduction faite des taxes et de 107,3 millions de dollars, BAIIA ajusté de 28,1 millions de dollars 1 , bénéfice net de 13,1 millions de dollars, [...]
Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data
24/11/2025
-- Zero Treatment Related Adverse Events observed during Cohort 7 (37mg capsules) DLT period – --Cohort 7 Pharmacokinetic (PK) profile continues to demonstrate dose-proportionality and Cmax/Cmin ratio <2. Achieved [...]
Genmab to Participate in a Fireside Chat at the Citi Global Healthcare Conference in Miami
24/11/2025
Media Release COPENHAGEN, Denmark; November 24, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its C hief F inancial O fficer Anthony Pagano will participate in a fireside chat at the Citi Global Healthcare [...]
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
24/11/2025
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Boundless Bio , (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with [...]
Managers’ transactions
24/11/2025
November 24, 2025 Announcement no. 28 Managers’ transactions In connection with the completion of BioPorto A/S’ directed issue as described in company announcement no. 27, BioPorto A/S has received notification pursuant [...]
BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes
24/11/2025
24 November 2025 Announcement no. 27 BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes Completion of share capital increase COPENHAGEN, DENMARK, 24 November [...]
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
24/11/2025
Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its October 27th Registered Direct Offering MILAN, Italy and NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: [...]
Rakovina Therapeutics Showcases Compelling Preclinical Data on AI-Discovered CNS-Penetrant ATR/mTOR Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting
24/11/2025
Variational AI’s Enki™ generative AI platform designed novel ATR/mTOR dual inhibitors with brain penetrance and activity in PTEN-deficient tumor models VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- [...]
DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meeting
24/11/2025
Monday 24 November DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of 2025 Annual General Meeting The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital [...]
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
24/11/2025
EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business
24/11/2025
Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 24 November 2025 – 7:00 AM CET Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key [...]
Sequana Medical Announces First U.S. Commercial alfapump® Implantation at Mount Sinai Hospital in New York
24/11/2025
Ghent, Belgium, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosis Feedback from hepatology community [...]
Nanox Announces $15 Million Registered Direct Offering of Common Stock
24/11/2025
PETACH TIKVA, Israel, Nov. 23, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has entered into a [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
21/11/2025
SAN CARLOS, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
21/11/2025
PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES TORONTO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. ( TSXV: [...]
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
21/11/2025
SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21/11/2025
NOVATO, Calif., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December
21/11/2025
TEL AVIV, Israel, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and other members of executive management [...]
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
21/11/2025
ROCKVILLE, Md., Nov. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]

Pages